Follow
Michael Cantrell, Ph.D.
Michael Cantrell, Ph.D.
Sr. Director, Oncology at Bristol-Myers Squibb
Verified email at bms.com
Title
Cited by
Cited by
Year
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture
X Li, L Nadauld, A Ootani, DC Corney, RK Pai, O Gevaert, MA Cantrell, ...
Nature medicine 20 (7), 769-777, 2014
4242014
Chemodetection and destruction of host urea allows Helicobacter pylori to locate the epithelium
JY Huang, EG Sweeney, M Sigal, HC Zhang, SJ Remington, MA Cantrell, ...
Cell host & microbe 18 (2), 147-156, 2015
1812015
c-Jun N-terminal kinases mediate a wide range of targets in the metastatic cascade
ND Ebelt, MA Cantrell, CL Van Den Berg
Genes & cancer 4 (9-10), 378-387, 2013
702013
Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model
P Chen, JF O'Neal, ND Ebelt, MA Cantrell, S Mitra, A Nasrazadani, ...
PloS one 5 (5), e10443, 2010
612010
Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration
TS Kaoud, S Mitra, S Lee, J Taliaferro, M Cantrell, KD Linse, ...
ACS chemical biology 6 (6), 658-666, 2011
532011
Organoid modeling for cancer precision medicine
MA Cantrell, CJ Kuo
Genome medicine 7, 1-3, 2015
422015
c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8)
S Mitra, JS Lee, M Cantrell, CL Van Den Berg
Journal of Biological Chemistry 286 (17), 15287-15297, 2011
402011
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
MA Cantrell, ND Ebelt, AD Pfefferle, CM Perou, CL Van Den Berg
Oncotarget 6 (14), 11863, 2015
132015
Gastrointestinal organoid cultures for functional evaluation of oncogenic loci.
AA Salahudeen, X Li, M Cantrell, CJ Kuo
Journal of Clinical Oncology 33 (3_suppl), 85-85, 2015
42015
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis
AA Salahudeen, JA Seoane, K Yuki, AT Mah, AR Smith, K Kolahi, M Sean, ...
Cell reports 42 (11), 2023
2023
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite US study
C Willis, H Bauer, TH Au, J Menon, S Unni, D Tran, Z Rivers, W Akerley, ...
Oncotarget 13, 1306, 2022
2022
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite US study
C Willis, H Bauer, TH Au, J Menon, S Unni, D Tran, Z Rivers, W Akerley, ...
Oncotarget 13, 257, 2022
2022
Pan-cancer organoid validation of tumor outlier chromosomal amplification events
AA Salahudeen, K Yuki, JA Seoane, AT Mah, AR Smith, K Kolahi, ...
bioRxiv, 2021.10. 05.463147, 2021
2021
Abstract LB-34: 3-Dimensional air-liquid interface organoid culture of primary human tumor biopsies
JT Neal, M Cantrell, P Rack, CJ Kuo
Cancer Research 74 (19_Supplement), LB-34-LB-34, 2014
2014
JNK2 inhibits luminal cell commitment in normal mammary glands and tumors
MA Cantrell
2013
PD08-01: JNK2 Regulates Mammary Lineage Differentiation in Tumors and Normal Glands through Notch1 and p53.
MA Cantrell, ND Ebelt, BCL Van Den
Cancer Research 71 (24_Supplement), PD08-01-PD08-01, 2011
2011
cJun N-terminal Kinase 2 (JNK2) enhances cell migration through Epidermal Growth Factor Substrate 8 (EPS8) Shreya Mitra1, 2, Ju-Seog Lee2, Michael Cantrell3, Carla Lynn Van Den …
S Mitra, JS Lee, M Cantrell
2011
Abstract P5-06-15: JNK2 Regulates Mammary Epithelial Cell Differentiation Through Inhibition of p53 and Notch-1 Expression
M Cantrell, ND Ebelt, CL Van Den Berg
Cancer Research 70 (24_Supplement), P5-06-15-P5-06-15, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–18